/PRNewswire/ Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD), today announced that Louise Modis, PhD, has joined the.
Capturing Covid-19: Start-up Aqdot uses molecular science to improve air quality prospectmagazine.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prospectmagazine.co.uk Daily Mail and Mail on Sunday newspapers.
Ian Churcher of Amphista highlights opportunities and how the next generation of targeted protein degradation (TPD) therapy are developing to overcome existing limitations.